List View Detail View 276-300 of 332 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 11 12 13 ... 14 Next Product Clone Appl. Reg Cat# Size Price Quantity Purified anti-human CD224 Antibody KF29 FC RUO 394302 100 µg 212€ TotalSeq™-A1052 anti-human CD224 Antibody KF29 PG RUO 394311 10 µg 296€ TotalSeq™-B1052 anti-human CD224 Antibody KF29 PG RUO 394309 10 µg 296€ TotalSeq™-C1052 anti-human CD224 Antibody KF29 PG RUO 394307 10 µg 296€ Biotin anti-mouse CD229 (Ly-9) Antibody Ly9ab3 FC RUO 122903 50 µg 67€ Purified anti-mouse CD229 (Ly-9) Antibody Ly9ab3 FC RUO 122901 50 µg 57€ FITC anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364207 25 tests 62€ 364208 100 tests 141€ APC anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364205 25 tests 76€ 364206 100 tests 176€ PE anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364203 25 tests 79€ 364204 100 tests 181€ Purified anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICFC, FC RUO 364202 100 µg 310€ TotalSeq™-B1453 anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICPG RUO 364209 10 µg 296€ TotalSeq™-C1453 anti-human CD222 (IGF2R) Recombinant Antibody QA19A18 ICPG RUO 364211 10 µg 296€ Ultra-LEAF™ Purified anti-mouse CD223 (LAG-3) Recombinant Antibody QA20A93 FC RUO 109703 100 µg 88€ 109704 1 mg 120€ Purified anti-human CD228 (MFI2, MTF1) Antibody SHM72 FC RUO 363101 100 µg 212€ FITC anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337104 100 tests 184€ PE anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337106 100 tests 210€ Purified anti-human CD226 (DNAM-1) Antibody TX25 FC RUO 337102 100 µg 100€ TotalSeq™-A0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337111 10 µg 296€ TotalSeq™-B0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337115 10 µg 296€ TotalSeq™-C0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337113 10 µg 296€ TotalSeq™-D0805 anti-human CD226 (DNAM-1) Antibody TX25 PG RUO 337117 10 µg 296€ Results Per Page: 25 50 100 200 Previous 1 ... 11 12 13 ... 14 Next
Follow Us